Indeed, SETD2 mutations in ccRCC tumors are associated with changes in chromatin accessibility and DNA methylation (Buck et al., 2014) or widespread RNA processing defects (Simon et al., 2014). This evidence concerns the gene SETD2 and nonpapillary renal cell carcinoma.